{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:28:44Z","timestamp":1769520524714,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["09.3.3-LMT-K-712-01-0041"],"award-info":[{"award-number":["09.3.3-LMT-K-712-01-0041"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Massively parallel sequencing of maternal cell-free DNA (cfDNA) is widely used to test fetal genetic abnormalities in non-invasive prenatal testing (NIPT). However, sequencing-based approaches are still of high cost. Building upon previous knowledge that placenta, the main source of fetal circulating DNA, is hypomethylated in comparison to maternal tissue counterparts of cfDNA, we propose that targeting either unmodified or 5-hydroxymethylated CG sites specifically enriches fetal genetic material and reduces numbers of required analytical sequencing reads thereby decreasing cost of a test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We employed uTOPseq and hmTOP-seq approaches which combine covalent derivatization of unmodified or hydroxymethylated CG sites, respectively, with next generation sequencing, or quantitative real-time PCR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We detected increased 5-hydroxymethylcytosine (5hmC) levels in fetal chorionic villi (CV) tissue samples as compared with peripheral blood. Using our previously developed uTOP-seq and hmTOP-seq approaches we obtained whole-genome uCG and 5hmCG maps of 10 CV tissue and 38 cfDNA samples in total. Our results indicated that, in contrast to conventional whole genome sequencing, such epigenomic analysis highly specifically enriches fetal DNA fragments from maternal cfDNA. While both our approaches yielded 100% accuracy in detecting Down syndrome in fetuses, hmTOP-seq maintained such accuracy at ultra-low sequencing depths using only one million reads. We identified 2164 and 1589 placenta-specific differentially modified and 5-hydroxymethylated regions, respectively, in chromosome 21, as well as 3490 and 2002 Down syndrome-specific differentially modified and 5-hydroxymethylated regions, respectively, that can be used as biomarkers for identification of Down syndrome or other epigenetic diseases of a fetus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>uTOP-seq and hmTOP-seq approaches provide a cost-efficient and sensitive epigenetic analysis of fetal abnormalities in maternal cfDNA. The results demonstrated that T21 fetuses contain a perturbed epigenome and also indicated that fetal cfDNA might originate from fetal tissues other than placental chorionic villi. Robust covalent derivatization followed by targeted analysis of fetal DNA by sequencing or qPCR presents an attractive strategy that could help achieve superior sensitivity and specificity in prenatal diagnostics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-020-00938-x","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:03:50Z","timestamp":1603188230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing"],"prefix":"10.1186","volume":"12","author":[{"given":"Juozas","family":"Gordevi\u010dius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milda","family":"Narmont\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Povilas","family":"Gibas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotryna","family":"Kvederavi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vita","family":"Tomkut\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priit","family":"Paluoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaarel","family":"Krjut\u0161kov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Salumets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4094-456X","authenticated-orcid":false,"given":"Edita","family":"Kriukien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"938_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/bdra.20735","volume":"88","author":"SE Parker","year":"2010","unstructured":"Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004\u20132006. Birth Defects Res Part A Clin Mol Teratol. 2010;88:1008\u201316.","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"938_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/uog.14636","volume":"45","author":"R Akolekar","year":"2015","unstructured":"Akolekar R, Beta J, Picciarelli G, Ogilvie C, D\u2019Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16\u201326.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"938_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(05)63449-6","volume":"350","author":"YM Dennis Lo","year":"1997","unstructured":"Dennis Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485\u20137.","journal-title":"Lancet"},{"key":"938_CR4","doi-asserted-by":"publisher","first-page":"19920","DOI":"10.1073\/pnas.0810373105","volume":"105","author":"FMF Lun","year":"2008","unstructured":"Lun FMF, Tsui NBY, Chan KCA, Leung TY, Lau TK, Charoenkwan P, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105:19920\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"938_CR5","doi-asserted-by":"publisher","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","volume":"2","author":"YMD Lo","year":"2010","unstructured":"Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang P, Lun FMF, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:61ra91.","journal-title":"Sci Transl Med."},{"key":"938_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrg1982","volume":"8","author":"YM Dennis Lo","year":"2007","unstructured":"Dennis Lo YM, Chiu RWK. Innovations: prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet. 2007;8:71\u20137.","journal-title":"Nat Rev Genet"},{"key":"938_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","volume":"50","author":"KCA Chan","year":"2004","unstructured":"Chan KCA, Zhang J, Hui ABY, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and Fetal DNA in maternal plasma. Clin Chem. 2004;50:88\u201392.","journal-title":"Clin Chem"},{"key":"938_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1373\/clinchem.2003.029835","volume":"50","author":"Y Li","year":"2004","unstructured":"Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem. 2004;50:1002\u201311.","journal-title":"Clin Chem"},{"key":"938_CR9","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1373\/clinchem.2010.144188","volume":"56","author":"HC Fan","year":"2010","unstructured":"Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clin Chem. 2010;56:1279\u201386.","journal-title":"Clin Chem"},{"key":"938_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2353\/ajpath.2009.081038","volume":"174","author":"EA Papageorgiou","year":"2009","unstructured":"Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, Lamnissou K, et al. Sites of differential DNA methylation between placenta and peripheral blood: Molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol. 2009;174:1609\u201318.","journal-title":"Am J Pathol"},{"key":"938_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/pd.3947","volume":"32","author":"E Tsaliki","year":"2012","unstructured":"Tsaliki E, Papageorgiou EA, Spyrou C, Koumbaris G, Kypri E, Kyriakou S, et al. MeDIP real-time qPCR of maternal peripheral blood reliably identifies trisomy 21. Prenat Diagn. 2012;32:996\u20131001.","journal-title":"Prenat Diagn"},{"key":"938_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1373\/clinchem.2009.134114","volume":"56","author":"YK Tong","year":"2010","unstructured":"Tong YK, Jin S, Chiu RWK, Ding C, Chan KCA, Leung TY, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem. 2010;56:90\u20138.","journal-title":"Clin Chem"},{"key":"938_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13059-015-0645-x","volume":"16","author":"TJ Jensen","year":"2015","unstructured":"Jensen TJ, Kim SK, Zhu Z, Chin C, Gebhard C, Lu T, et al. Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains. Genome Biol. 2015;16:78.","journal-title":"Genome Biol."},{"key":"938_CR14","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1373\/clinchem.2013.212274","volume":"59","author":"FMF Lun","year":"2013","unstructured":"Lun FMF, Chiu RWK, Sun K, Leung TY, Jiang P, Chan KCA, et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem. 2013;59:1583\u201394.","journal-title":"Clin Chem"},{"key":"938_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1373\/clinchem.2007.098731","volume":"54","author":"SSC Chim","year":"2008","unstructured":"Chim SSC, Jin S, Lee TYH, Lun FMF, Lee WS, Chan LYS, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem. 2008;54:500\u201311.","journal-title":"Clin Chem"},{"key":"938_CR16","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.1073\/pnas.0503335102","volume":"102","author":"SSC Chim","year":"2005","unstructured":"Chim SSC, Tong YK, Chiu RWK, Lau TK, Leung TN, Chan LYS, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA. 2005;102:14753\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"938_CR17","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1073\/pnas.0810641105","volume":"105","author":"RWK Chiu","year":"2008","unstructured":"Chiu RWK, Chan KCA, Gao Y, Lau VYM, Zheng W, Leung TY, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105:20458\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"938_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1472-6483(10)60713-4","volume":"15","author":"RW Old","year":"2007","unstructured":"Old RW, Crea F, Puszyk W, Hult\u00e9n MA. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online. 2007;15:227\u201335.","journal-title":"Reprod Biomed Online"},{"key":"938_CR19","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1017\/S0016672316000136","volume":"98","author":"A Keravnou","year":"2016","unstructured":"Keravnou A, Ioannides M, Tsangaras K, Loizides C, Hadjidaniel MD, Papageorgiou EA, et al. Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions. Genet Res (Camb). 2016;98:e15.","journal-title":"Genet Res (Camb)"},{"key":"938_CR20","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ng1598","volume":"37","author":"M Weber","year":"2005","unstructured":"Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 2005;37:853\u201362.","journal-title":"Nat Genet"},{"key":"938_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315\u201322.","journal-title":"Nature"},{"key":"938_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nbt.1732","volume":"29","author":"C-X Song","year":"2011","unstructured":"Song C-X, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. 2011;29:68\u201372.","journal-title":"Nat Biotechnol"},{"key":"938_CR23","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/ncomms3190","volume":"4","author":"E Kriukien\u0117","year":"2013","unstructured":"Kriukien\u0117 E, Labrie V, Khare T, Urbanavi\u010di\u016bt\u0117 G, Lapinait\u0117 A, Koncevi\u010dius K, et al. DNA unmethylome profiling by covalent capture of CpG sites. Nat Commun. 2013;4:2190.","journal-title":"Nat Commun"},{"issue":"554\u2013564","key":"938_CR24","first-page":"e6","volume":"65","author":"Z Sta\u0161evskij","year":"2017","unstructured":"Sta\u0161evskij Z, Gibas P, Gordevi\u010dius J, Kriukien\u0117 E, Klima\u0161auskas S. Tethered oligonucleotide-primed sequencing, TOP-Seq: a high-resolution economical approach for DNA epigenome profiling. Mol Cell. 2017;65(554\u2013564):e6.","journal-title":"Mol Cell"},{"key":"938_CR25","doi-asserted-by":"publisher","first-page":"e3000684","DOI":"10.1371\/journal.pbio.3000684","volume":"18","author":"P Gibas","year":"2020","unstructured":"Gibas P, Narmont\u0117 M, Sta\u0161evskij Z, Gordevi\u010dius J, Klima\u0161auskas S, Kriukien\u0117 E. Precise genomic mapping of 5-hydroxymethylcytosine via covalent tether-directed sequencing. PLOS Biol. 2020;18:e3000684.","journal-title":"PLOS Biol"},{"key":"938_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/pd.5079","volume":"37","author":"DM van Beek","year":"2017","unstructured":"van Beek DM, Straver R, Weiss MM, Boon EMJ, Huijsdens-van Amsterdam K, Oudejans CBM, et al. Comparing methods for fetal fraction determination and quality control of NIPT samples. Prenat Diagn. 2017;37:769\u201373.","journal-title":"Prenat Diagn"},{"key":"938_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/pd.4615","volume":"35","author":"SK Kim","year":"2015","unstructured":"Kim SK, Hannum G, Geis J, Tynan J, Hogg G, Zhao C, et al. Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts. Prenat Diagn. 2015;35:810\u20135.","journal-title":"Prenat Diagn"},{"key":"938_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1101\/gr.126417.111","volume":"22","author":"CE Nestor","year":"2012","unstructured":"Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D, et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012;22:467\u201377.","journal-title":"Genome Res"},{"key":"938_CR29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1373\/clinchem.2011.165910","volume":"57","author":"AJ Sehnert","year":"2011","unstructured":"Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem. 2011;57:1042\u20139.","journal-title":"Clin Chem"},{"key":"938_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13059-016-0926-z","volume":"17","author":"TR Gaunt","year":"2016","unstructured":"Gaunt TR, Shihab HA, Hemani G, Min JL, Woodward G, Lyttleton O, et al. Systematic identification of genetic influences on methylation across the human life course. Genome Biol. 2016;17:61.","journal-title":"Genome Biol"},{"key":"938_CR31","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/gb-2014-15-3-r49","volume":"15","author":"L Wen","year":"2014","unstructured":"Wen L, Li X, Yan L, Tan Y, Li R, Zhao Y, et al. Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol. 2014;15:R49.","journal-title":"Genome Biol"},{"key":"938_CR32","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1214\/08-AOAS191","volume":"2","author":"A Gelman","year":"2008","unstructured":"Gelman A, Jakulin A, Pittau MG, Su YS. A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat. 2008;2:1360\u201383.","journal-title":"Ann Appl Stat"},{"key":"938_CR33","doi-asserted-by":"publisher","first-page":"e1003515","DOI":"10.1371\/journal.pgen.1003515","volume":"9","author":"S Jin","year":"2013","unstructured":"Jin S, Lee YK, Lim YC, Zheng Z, Lin XM, Ng DPY, et al. Global DNA hypermethylation in down syndrome placenta. PLoS Genet. 2013;9:e1003515.","journal-title":"PLoS Genet"},{"key":"938_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.12.2043","volume-title":"The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome","author":"G Brodsky","year":"1997","unstructured":"Brodsky G, Barnes T, Bleskan J, Becker L, Cox M, Patterson D. The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome. Oxford: Oxford University Press; 1997."},{"key":"938_CR35","first-page":"1727","volume":"25","author":"J Lu","year":"2016","unstructured":"Lu J, Mccarter M, Lian G, Esposito G, Capoccia E, Delli-Bovi LC, et al. Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression. Hum Mol Genet. 2016;25:1727.","journal-title":"Hum Mol Genet"},{"key":"938_CR36","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.4049\/jimmunol.1003053","volume":"187","author":"FA Lima","year":"2011","unstructured":"Lima FA, Moreira-Filho CA, Ramos PL, Brentani H, Lima LA, Arrais M, et al. Decreased AIRE expression and global thymic hypofunction in Down syndrome. J Immunol. 2011;187:3422\u201330.","journal-title":"J Immunol."},{"key":"938_CR37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/pd.5578","volume":"39","author":"O \u017dilina","year":"2019","unstructured":"\u017dilina O, Rekker K, Kaplinski L, Sauk M, Paluoja P, Teder H, et al. Creating basis for introducing non-invasive prenatal testing in the Estonian public health setting. Prenat Diagn. 2019;39:1262\u20138.","journal-title":"Prenat Diagn"},{"key":"938_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/nar\/gky1263","volume":"47","author":"L Raman","year":"2019","unstructured":"Raman L, Dheedene A, De Smet M, Van Dorpe J, Menten B. WisecondorX: improved copy number detection for routine shallow whole-genome sequencing. Nucleic Acids Res. 2019;47:1605\u201314.","journal-title":"Nucleic Acids Res"},{"key":"938_CR39","first-page":"13","volume":"6","author":"M Kazemi","year":"2017","unstructured":"Kazemi M, Salehi M, Kheirollahi M. MeDIP real-time qPCR has the potential for noninvasive prenatal screening of fetal trisomy 21. Int J Mol Cell Med. 2017;6:13\u201321.","journal-title":"Int J Mol Cell Med"},{"key":"938_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jmoldx.2015.12.002","volume":"18","author":"DE Lee","year":"2016","unstructured":"Lee DE, Lim JH, Kim MH, Park SY, Ryu HM. Novel epigenetic markers on chromosome 21 for noninvasive prenatal testing of fetal trisomy 21. J Mol Diagnostics. 2016;18:378\u201387.","journal-title":"J Mol Diagnostics"},{"key":"938_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm.2312","volume":"17","author":"EA Papageorgiou","year":"2011","unstructured":"Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med. 2011;17:510\u20133.","journal-title":"Nat Med"},{"key":"938_CR42","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1038\/s41598-018-23589-8","volume":"8","author":"M Sauk","year":"2018","unstructured":"Sauk M, \u017dilina O, Kurg A, Ustav EL, Peters M, Paluoja P, et al. NIPTmer: rapid k-mer-based software package for detection of fetal aneuploidies. Sci Rep. 2018;8:5616.","journal-title":"Sci Rep."},{"key":"938_CR43","first-page":"1.36.1","volume":"2016","author":"V Masevi\u010dius","year":"2016","unstructured":"Masevi\u010dius V, Nainyt\u0117 M, Klima\u0161auskas S. Synthesis of S-adenosyl-L-methionine analogs with extended transferable groups for methyltransferase-directed labeling of DNA and RNA. Curr Protoc Nucleic Acid Chem. 2016;2016:1.36.1-1.36.13.","journal-title":"Curr Protoc Nucleic Acid Chem"},{"key":"938_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011;17:10.","journal-title":"EMBnet.journal"},{"key":"938_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004420100716","volume":"129","author":"P Legendre","year":"2001","unstructured":"Legendre P, Gallagher ED. Ecologically meaningful transformations for ordination of species data. Oecologia. 2001;129:271\u201380.","journal-title":"Oecologia"},{"key":"938_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2307\/1942268","volume":"27","author":"JR Bray","year":"1957","unstructured":"Bray JR, Curtis JT. An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr. 1957;27:325\u201349.","journal-title":"Ecol Monogr"},{"key":"938_CR47","doi-asserted-by":"publisher","first-page":"btw495","DOI":"10.1093\/bioinformatics\/btw495","volume":"32","author":"T Gao","year":"2016","unstructured":"Gao T, He B, Liu S, Zhu H, Tan K, Qian J. EnhancerAtlas: a resource for enhancer annotation and analysis in 105 human cell\/tissue types. Bioinformatics. 2016;32:btw495.","journal-title":"Bioinformatics"},{"key":"938_CR48","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish A, Diekhans M, Ferreira A-M, Johnson R, Jungreis I, Loveland J, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47:D766\u201373.","journal-title":"Nucleic Acids Res"},{"key":"938_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2164-15-51","volume":"15","author":"H Naeem","year":"2014","unstructured":"Naeem H, Wong NC, Chatterton Z, Hong MKH, Pedersen JS, Corcoran NM, et al. Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014;15:51.","journal-title":"BMC Genomics"},{"issue":"19","key":"938_CR50","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1093\/bioinformatics\/btx346","volume":"33","author":"B Gel","year":"2017","unstructured":"Gel B, Serra E. karyoploteR: an R\/Bioconductor package to plot customizable genomes displaying arbitrary data and 2 CIBERONC. Bioinformatics. 2017;33(19):3088\u201390.","journal-title":"Bioinformatics"},{"key":"938_CR51","unstructured":"R Core Team. R: a language and environment for statistical computing. 2018. https:\/\/www.r-project.org\/."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00938-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00938-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00938-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T23:34:54Z","timestamp":1634686494000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00938-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00938-x","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Ethics Committee of the University of Tartu (246\/T-21 and 213\/T-21) and written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"E.K., J.G., M.N. and P.G. are authors of a patent application related to NIPT based on TOP-seq strategies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}